Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Undergraduate | 4 | 2016 | 86 | 1.480 |
Why?
|
| Geriatrics | 4 | 2017 | 85 | 1.470 |
Why?
|
| Accidental Falls | 5 | 2016 | 222 | 1.390 |
Why?
|
| Models, Educational | 2 | 2014 | 20 | 0.910 |
Why?
|
| Gait | 4 | 2014 | 142 | 0.860 |
Why?
|
| Risk Assessment | 5 | 2017 | 1429 | 0.850 |
Why?
|
| Clinical Competence | 6 | 2018 | 333 | 0.820 |
Why?
|
| Internal Medicine | 2 | 2019 | 54 | 0.790 |
Why?
|
| Curriculum | 4 | 2019 | 214 | 0.780 |
Why?
|
| Patient Readmission | 2 | 2019 | 126 | 0.750 |
Why?
|
| Faculty, Medical | 2 | 2019 | 78 | 0.730 |
Why?
|
| Staff Development | 1 | 2019 | 16 | 0.690 |
Why?
|
| Teaching | 2 | 2019 | 63 | 0.690 |
Why?
|
| Holidays | 1 | 2019 | 3 | 0.670 |
Why?
|
| Cognition | 5 | 2013 | 556 | 0.670 |
Why?
|
| Continuity of Patient Care | 2 | 2019 | 69 | 0.660 |
Why?
|
| Education, Medical | 1 | 2019 | 69 | 0.660 |
Why?
|
| Students, Medical | 3 | 2016 | 131 | 0.640 |
Why?
|
| Teaching Rounds | 1 | 2018 | 6 | 0.620 |
Why?
|
| Physical Examination | 1 | 2018 | 92 | 0.590 |
Why?
|
| Geriatric Assessment | 5 | 2014 | 390 | 0.590 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 75 | 0.580 |
Why?
|
| Aging | 6 | 2014 | 946 | 0.570 |
Why?
|
| Internship and Residency | 3 | 2017 | 313 | 0.560 |
Why?
|
| Motor Activity | 3 | 2009 | 325 | 0.540 |
Why?
|
| Aged | 28 | 2019 | 10314 | 0.510 |
Why?
|
| Food Services | 1 | 2014 | 20 | 0.480 |
Why?
|
| Health Personnel | 1 | 2014 | 121 | 0.420 |
Why?
|
| Cognition Disorders | 4 | 2013 | 385 | 0.400 |
Why?
|
| Walking | 4 | 2007 | 209 | 0.400 |
Why?
|
| Depression | 4 | 2014 | 445 | 0.380 |
Why?
|
| Humans | 33 | 2019 | 32114 | 0.370 |
Why?
|
| Educational Measurement | 3 | 2016 | 123 | 0.340 |
Why?
|
| Female | 26 | 2019 | 20015 | 0.300 |
Why?
|
| Women's Health | 1 | 2009 | 235 | 0.300 |
Why?
|
| Body Composition | 2 | 2007 | 397 | 0.270 |
Why?
|
| Male | 23 | 2019 | 19217 | 0.260 |
Why?
|
| Health Status | 2 | 2007 | 400 | 0.260 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 158 | 0.240 |
Why?
|
| Risk Factors | 12 | 2019 | 3880 | 0.230 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2009 | 135 | 0.230 |
Why?
|
| North Carolina | 3 | 2019 | 1538 | 0.210 |
Why?
|
| Fractures, Bone | 2 | 2014 | 148 | 0.200 |
Why?
|
| Time Factors | 2 | 2019 | 2151 | 0.170 |
Why?
|
| Video Recording | 1 | 2019 | 59 | 0.170 |
Why?
|
| Program Development | 1 | 2019 | 97 | 0.170 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 184 | 0.170 |
Why?
|
| Hip Fractures | 1 | 2017 | 31 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2017 | 75 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2018 | 129 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 2265 | 0.140 |
Why?
|
| Communication | 1 | 2018 | 142 | 0.140 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 3990 | 0.130 |
Why?
|
| Education | 1 | 2016 | 38 | 0.130 |
Why?
|
| Prospective Studies | 6 | 2016 | 2283 | 0.130 |
Why?
|
| Adult | 3 | 2019 | 9380 | 0.130 |
Why?
|
| Double-Blind Method | 4 | 2009 | 525 | 0.130 |
Why?
|
| Comorbidity | 4 | 2017 | 566 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2016 | 186 | 0.130 |
Why?
|
| Hypertension | 2 | 2014 | 960 | 0.120 |
Why?
|
| Hemoglobins | 2 | 2005 | 49 | 0.120 |
Why?
|
| Telemedicine | 1 | 2016 | 102 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2014 | 1428 | 0.120 |
Why?
|
| Middle Aged | 8 | 2019 | 11839 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2013 | 59 | 0.110 |
Why?
|
| United States | 4 | 2017 | 3976 | 0.110 |
Why?
|
| Vitamin D | 1 | 2014 | 184 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2013 | 464 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2013 | 161 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2012 | 1128 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 352 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 181 | 0.090 |
Why?
|
| Research Support as Topic | 1 | 2010 | 26 | 0.090 |
Why?
|
| Arteries | 1 | 2010 | 67 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 2005 | 519 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2012 | 494 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3510 | 0.080 |
Why?
|
| Dementia | 2 | 2009 | 252 | 0.080 |
Why?
|
| Fosinopril | 1 | 2009 | 2 | 0.080 |
Why?
|
| Fibrinolysis | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cystatins | 1 | 2008 | 8 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2007 | 73 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 783 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 765 | 0.070 |
Why?
|
| Weight Lifting | 1 | 2006 | 10 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 143 | 0.070 |
Why?
|
| Exercise Test | 1 | 2007 | 227 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 1 | 2006 | 90 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2005 | 9 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 1199 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 249 | 0.060 |
Why?
|
| Social Class | 1 | 2005 | 90 | 0.060 |
Why?
|
| Smoking | 2 | 2008 | 528 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2007 | 1817 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 327 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 257 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2006 | 270 | 0.060 |
Why?
|
| Italy | 4 | 2004 | 15 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 401 | 0.050 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2003 | 5 | 0.050 |
Why?
|
| Pennsylvania | 2 | 2014 | 83 | 0.050 |
Why?
|
| Antioxidants | 1 | 2004 | 115 | 0.050 |
Why?
|
| Tennessee | 2 | 2014 | 102 | 0.050 |
Why?
|
| Prognosis | 1 | 2007 | 1497 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2004 | 240 | 0.050 |
Why?
|
| Inpatients | 1 | 2003 | 85 | 0.050 |
Why?
|
| Inflammation | 1 | 2005 | 530 | 0.050 |
Why?
|
| Diet | 1 | 2004 | 391 | 0.050 |
Why?
|
| Quality of Life | 1 | 2007 | 946 | 0.050 |
Why?
|
| Brain | 1 | 2008 | 951 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 255 | 0.040 |
Why?
|
| Hospitalization | 1 | 2002 | 470 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2008 | 923 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2014 | 845 | 0.040 |
Why?
|
| Obesity | 1 | 2005 | 1176 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 16 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 97 | 0.040 |
Why?
|
| ROC Curve | 1 | 2017 | 164 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2009 | 95 | 0.040 |
Why?
|
| Absenteeism | 1 | 2016 | 11 | 0.030 |
Why?
|
| Observation | 1 | 2016 | 25 | 0.030 |
Why?
|
| Peer Group | 1 | 2016 | 44 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 770 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 406 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 101 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2008 | 191 | 0.030 |
Why?
|
| Age Distribution | 2 | 2008 | 206 | 0.030 |
Why?
|
| Physicians | 1 | 2017 | 159 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2017 | 227 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2014 | 49 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 74 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 989 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 25 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2014 | 363 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 321 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 753 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 371 | 0.030 |
Why?
|
| Postmenopause | 1 | 2013 | 430 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 26 | 0.020 |
Why?
|
| Elasticity | 1 | 2010 | 36 | 0.020 |
Why?
|
| Efficiency | 1 | 2010 | 18 | 0.020 |
Why?
|
| Bone Density | 1 | 2012 | 205 | 0.020 |
Why?
|
| Research | 1 | 2010 | 74 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2014 | 1166 | 0.020 |
Why?
|
| Publishing | 1 | 2010 | 60 | 0.020 |
Why?
|
| Motivation | 1 | 2010 | 113 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 48 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2665 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2009 | 18 | 0.020 |
Why?
|
| Cystatin C | 1 | 2008 | 31 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2008 | 54 | 0.020 |
Why?
|
| Ginkgo biloba | 1 | 2007 | 19 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 198 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 181 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 31 | 0.020 |
Why?
|
| Canada | 1 | 2007 | 56 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2008 | 237 | 0.020 |
Why?
|
| Arthralgia | 1 | 2006 | 33 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 186 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 594 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2006 | 131 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 44 | 0.020 |
Why?
|
| Knee Joint | 1 | 2006 | 142 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 315 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 510 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 238 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 247 | 0.010 |
Why?
|
| Anemia | 1 | 2004 | 58 | 0.010 |
Why?
|
| Vitamins | 1 | 2004 | 68 | 0.010 |
Why?
|
| Digoxin | 1 | 2003 | 4 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2003 | 9 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 2003 | 12 | 0.010 |
Why?
|
| Diuretics | 1 | 2003 | 26 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1542 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 125 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 97 | 0.010 |
Why?
|
| Pharmacoepidemiology | 1 | 2002 | 2 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 78 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 72 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2003 | 122 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 765 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2003 | 472 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 876 | 0.010 |
Why?
|
| Exercise | 1 | 2006 | 673 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 355 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 324 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 881 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 919 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 3306 | 0.010 |
Why?
|